SNHG17 and hepatocellular carcinoma: In hepatocellular carcinoma, SNHG17 promotes cancer hallmarks and epithelial–mesenchymal transition by interfering with the control of RFX1 (regulatory factor X1) by serving as a ceRNA of miR-3180-3p, which, in turn, leads to the overexpression of RFX1, a growth-stimulatory transcription factor with oncogenic potential that controls the expression of several cancer-relevant proteins in a cell [80].